Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

31 results
Display

The Effects of Etidronate on Bone Loss after Renal Transplantation

Lim SK

  • KMID: 1837605
  • J Korean Soc Endocrinol.
  • 2001 Oct;16(4-5):422-425.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Intermittent Cyclic Etidronate Treatment on Bone Mineral Density of Postmenopausal Osteoporosis: Comparison with Continuous Estrogen Therapy

Lee Y, Yoo C, Shin K, Kang S, Lee E, Baek H, Kim H, Choi S, Lim K, Choi Y, Song Y

  • KMID: 1544924
  • J Korean Rheum Assoc.
  • 1999 Mar;6(1):44-52.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risedronate-related Localized Amnesia in an Elderly Patient with Osteoporosis

Ko KD, Cho BL

Osteoporosis is the most common metabolic bone disease that results in an increased risk of fragility fractures. Bisphosphonates are commonly used in the treatment of osteoporosis. Concerns about their association...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Experimental Study of Disodium Etidronate for the Growth of MC3T3-E1 Osteoblastic Cell Line

Yoo MC, Ahn JH, Han JS, Cho KH, Kim BS

In the general, Disodium estdronate (EHDP) had effects of inhibition in bone resorption, dissolution of hydroxyapatite crystal and decreasing the turn over rate in Paget's disease. Clinically it is used...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Vitamin D Deficiency with Secondary Hyperparathyroidism and Brown Tumor

Lee MK, Kang WS, Kim TH, Lee JH, Kim SH

  • KMID: 2314121
  • Osteoporosis.
  • 2012 Aug;10(2):90-96.
The importance of vitamin D for skeletal health is well known. Vitamin D deficiency causes secondary hyperparathyroidism, high bone turnover, bone loss, and osteoporotic fractures. We report a case of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Myositis Ossificans Progressiva

Park SY, Lee SJ, Chung JA, Lee SJ

  • KMID: 2335391
  • J Korean Pediatr Soc.
  • 1998 Nov;41(11):1601-1605.
Myositis ossificans progressiva (MOP) is a rare, slow progressive autosomal dominant disorder that principally affects children under the age 10 years. It is characterized by progressive fibroblastic proliferation, and subsequent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Osteonecrosis of the Jaw in a Patient with Osteoporosis Treated with Oral Bisphosphonates

Choi SW, Kim SR, Lee KB, Nam KW, Seo KB, Nam U, Kim HJ

Bisphosphonates are widely used in the management of metastatic bone disease and in the prevention of osteomalacia and osteoporosis. In particular, oral preparations are more commonly used for the prevension...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A study of root resorption and alveolar bone changes during tooth movement after treatment with etidronate disodium

Hwang CJ, Sohn BH

  • KMID: 2271228
  • Korean J Orthod.
  • 1991 Mar;21(1):77-92.
Many studies has been conducted concerning prevention of unnecessary complications such as root resorption during orthodontic tooth movement under various mechanical forces. Nowadays, the cause of the root resorption is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevention of New Vertebral Fractures after Treatment with Risedronate, Alendronate or Calcium Carbonate in Patients with Osteoporotic Compression Fracture Treated with Cement Augmentation

Kim JY, Moon ES, Lee HM, Moon SH, Park JO, Hyung JH, Kim HS

  • KMID: 2336206
  • J Korean Orthop Assoc.
  • 2009 Aug;44(4):436-441.
PURPOSE: To evaluate the rate of new fractures of the spine after risedronate, alendronate or calcium carbonate in patients who had vertebroplasty or kyphoplasty due to compression fracture. MATERIALS AND...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Etidronate Therapy on Osteoporosis in Spinal Cord Injury Patients

Kim SY, Kim CP, Kang BG, Lee YG

  • KMID: 2136819
  • J Korean Acad Rehabil Med.
  • 1997 Oct;21(5):867-873.
One of the sequelae of spinal cord trauma which start soon after the onset of injury is the loss of the calcium from bone. Bone mineral and matrix resorption causes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Bisphosphonate on Osteoblastic Activity of the Human Periodontal Ligament Cells in Vitro

Kim EY, Kim OS, Chung HJ

Previous studies have demonstrated an increase in bone mass and density with use of bisphosphonate in osteoporosis. This agent acts as an inhibitor of osteoclastic activity and results in increase...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Etidronate Disodium on Rat's Bone and Soft Tissue

Han SJ, Yoon TS, Lee SN, Heo Y, Kim JY, Lee KW

  • KMID: 2178461
  • J Korean Acad Rehabil Med.
  • 2006 Oct;30(5):496-501.
OBJECTIVE: To evaluate the effects of etidronate disodium on bone and soft tissue, especially on bone mineral density, and mucosal changes of the aorta and esophagus. METHOD: Male Sprague-Dawley rats were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis

Byun JH, Jang S, Lee S, Park S, Yoon HK, Yoon BH, Ha YC

BACKGROUND: The efficacy of bisphosphonates for osteoporotic fracture has been consistently reported in recent randomized controlled trials (RCTs) enrolling hundreds of patients. The objective of this study was to update...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Disodium Etidronate on Phosphatase Activity in Experimental bone Formation of Rats

Roh KJ, Ahn YS, Choi JY

The bone formation of periarticular connective tissue after head injury and total hip arthroplasty is included in the category of heterotopic ossification. Induction of a new bone formation in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Subsequent Hip Fracture in Osteoporotic Hip Fracture Patients

Kim HS, Lee SH, Moon KH

  • KMID: 2314084
  • Osteoporosis.
  • 2010 Dec;8(3):297-302.
OBJECTIVES: A significant number of patients who had a previous surgical treatment in the hip area experience subsequent hip fracture (SHF) on the opposite side. This study aims to analyze...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Comparision of Mitigative Effect of Alendronate and Risedronate on Particle-Induced Osteolysis: in Mouse Calvarian Model

Lee DS, Choi NY, Nah KH, Song HS, Do JH, Han SK

  • KMID: 2199069
  • J Korean Orthop Res Soc.
  • 2008 Apr;11(1):1-10.
PURPOSE: The purpose of this study was to compare the mitigative effect of alendronate and risedronate on osteolysis in the mouse calvarian model by using titanium (Ti) and polymethylmethacrylate (PMMA)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Carrier on Labeling and Biodistribution of Re-188-Hydroxyethylidene diphosphonate

Chang YS, Jeong JM, Kim BK, Cho JH, Lee DS, Chung JK, Lee SJ, Kim IK, Lee SE, Lee MC

  • KMID: 2256935
  • Korean J Nucl Med.
  • 2000 Aug;34(4):344-352.
PURPOSE: Re-188-Hydroxyethylidene diphosphonate (HEDP) is a new cost-effective agent for systemic radioisotope therapy of metastatic bone pain. We investigated the influence of carrier for labeling and biodistribution of Re-188-HEDP using HEDP kit...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fibrodysplasia Ossificans Progressiva

Choi IH, Chung CY, Cho TJ, Lee DY, Suk SI, Kim WJ, Cho HO, Lee CS, Yoo HW, Yun YH

  • KMID: 2189663
  • J Korean Orthop Assoc.
  • 1998 Aug;33(4):1069-1075.
Fibrodysplasia ossificans progressive (FOP) is an extremely rare disabling disorder characterized by progressive heterotopic ossification associated with congenital digital malformations. The purpose of this study is to delineate the problems...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Diagnosis and Treatment of Osteoporosis

Moon JS, Won KC

  • KMID: 2320113
  • Yeungnam Univ J Med.
  • 2008 Jun;25(1):19-30.
Osteoporosis, a disease characterized by low bone mass and microarchitectural deterioration of bone tissue leading to enhanced bone fragility and fracture risk, is a major public health problem. The diagnostic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the efficacy of three once-weekly bisphosphonates on bone mineral density gains in Korean women

Lee JH, Jee BC, Suh CS, Kim SH, Choi YM, Kim JG, Moon SY

  • KMID: 2313945
  • Obstet Gynecol Sci.
  • 2013 May;56(3):176-181.
OBJECTIVE: To assess the efficacies of once-weekly bisphosphonates on bone mineral density (BMD) gains in Korean women aged 50 years or more. METHODS: We selected 166 patients who received: alendronate 70...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr